2001
DOI: 10.1016/s0168-3659(01)00299-1
|View full text |Cite
|
Sign up to set email alerts
|

Structure and design of polymeric surfactant-based drug delivery systems

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

12
1,069
0
9

Year Published

2001
2001
2015
2015

Publication Types

Select...
4
3

Relationship

0
7

Authors

Journals

citations
Cited by 1,644 publications
(1,090 citation statements)
references
References 146 publications
12
1,069
0
9
Order By: Relevance
“…The method of preparation can also affect drug loading efficiency (for review, see Refs. 3,11). Rather low drug content (2% to 4% w/w) were achieved compared to the drug content in micelles formed from other PEGpolyesters.…”
Section: Discussionmentioning
confidence: 91%
See 1 more Smart Citation
“…The method of preparation can also affect drug loading efficiency (for review, see Refs. 3,11). Rather low drug content (2% to 4% w/w) were achieved compared to the drug content in micelles formed from other PEGpolyesters.…”
Section: Discussionmentioning
confidence: 91%
“…However, the incorporation of drugs into diblock polymeric micelles is usually a long and multi-step procedure, which often requires the use of organic solvents (for reviews, see Refs. 2,3,[10][11][12][13][14]. There are various methods for the incorporation of drugs in the blockcopolymer micelles.…”
Section: Introductionmentioning
confidence: 99%
“…It was clearly shown that micelles possess a number of unbeatable advantages as potential drug delivery systems for poorly soluble pharmaceuticals. 1,2 The hydrophobic core of micelles may be used as a cargo space for encapsulation of a variety of sparingly soluble therapeutic and diagnostic agents. Such encapsulation substantially increases their bioavailability, protects them from destructive factors upon parenteral administration, and beneficially modifies their pharmacokinetics and biodistribution.…”
Section: Introductionmentioning
confidence: 99%
“…Such encapsulation substantially increases their bioavailability, protects them from destructive factors upon parenteral administration, and beneficially modifies their pharmacokinetics and biodistribution. 1,2 The size of micelles permits their extravasation and accumulation in a variety of pathological sites, where the permeability of the vascular endothelium is increased, such as infarct zones and tumors. [3][4][5][6] This fact provides a unique opportunity for physiology-based targeting of drugs and/ or drug-loaded pharmaceutical carriers, such as micelles, to these pathological areas via the enhanced permeability and retention (EPR; or "passive" targeting) effect.…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation